CODX Co-Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CODX

Price (delayed)

$1.21

Market cap

$37.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.2

Enterprise value

$25.9M

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using ...

Highlights
CODX's EPS has dropped by 167% year-on-year but it is up by 14% since the previous quarter
CODX's net income has dropped by 148% year-on-year but it is up by 17% since the previous quarter
The company's gross profit has shrunk by 91% YoY and by 10% QoQ
Co-Diagnostics's gross margin has shrunk by 54% YoY and by 39% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://codiagnostics.com
Peers: OBIO

Key stats

What are the main financial stats of CODX
Market
Shares outstanding
31.26M
Market cap
$37.82M
Enterprise value
$25.9M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.43
Price to sales (P/S)
5.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.8
Earnings
Revenue
$6.81M
EBIT
-$38.11M
EBITDA
-$36.83M
Free cash flow
-$23.45M
Per share
EPS
-$1.2
Free cash flow per share
-$0.8
Book value per share
$2.81
Revenue per share
$0.23
TBVPS
$2.35
Balance sheet
Total assets
$95.32M
Total liabilities
$9.31M
Debt
$2.99M
Equity
$86.01M
Working capital
$56.39M
Liquidity
Debt to equity
0.03
Current ratio
10.81
Quick ratio
10.24
Net debt/EBITDA
0.32
Margins
EBITDA margin
-540.7%
Gross margin
38.6%
Net margin
-518.7%
Operating margin
-626.9%
Efficiency
Return on assets
-32.6%
Return on equity
-35.4%
Return on invested capital
-55.8%
Return on capital employed
-42.5%
Return on sales
-559.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CODX stock price

How has the Co-Diagnostics stock price performed over time
Intraday
0.83%
1 week
9.01%
1 month
8.04%
1 year
-13.57%
YTD
-9.02%
QTD
8.04%

Financial performance

How have Co-Diagnostics's revenue and profit performed over time
Revenue
$6.81M
Gross profit
$2.63M
Operating income
-$42.71M
Net income
-$35.33M
Gross margin
38.6%
Net margin
-518.7%
CODX's net income has dropped by 148% year-on-year but it is up by 17% since the previous quarter
The company's gross profit has shrunk by 91% YoY and by 10% QoQ
The revenue has plunged by 80% YoY but it has grown by 46% from the previous quarter
CODX's operating income has plunged by 58% YoY but it is up by 25% from the previous quarter

Growth

What is Co-Diagnostics's growth rate over time

Valuation

What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.43
P/S
5.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.8
CODX's EPS has dropped by 167% year-on-year but it is up by 14% since the previous quarter
The P/B is 88% below the 5-year quarterly average of 3.7 but 8% above the last 4 quarters average of 0.4
The equity has declined by 25% year-on-year and by 14% since the previous quarter
The P/S is 82% below the 5-year quarterly average of 29.1 but 2.2% above the last 4 quarters average of 5.1
The revenue has plunged by 80% YoY but it has grown by 46% from the previous quarter

Efficiency

How efficient is Co-Diagnostics business performance
CODX's return on sales has surged by 50% since the previous quarter
CODX's return on invested capital is up by 22% since the previous quarter
The ROA has grown by 12% from the previous quarter
CODX's return on equity is up by 11% since the previous quarter

Dividends

What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CODX.

Financial health

How did Co-Diagnostics financials performed over time
The current ratio has plunged by 55% YoY and by 23% from the previous quarter
Co-Diagnostics's quick ratio has shrunk by 53% YoY and by 19% QoQ
The company's debt is 97% lower than its equity
The equity has declined by 25% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.